Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Sale
Common Stock
2024-03-15$6.00/sh−50,000$300,000→ 984,476 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 6, 2023.